Naslov
Canonical Wnt/β-Catenin Signaling Pathway Is Dysregulated in Patients With Primary and Secondary Myelofibrosis

Autori
Lucijanić, Marko ; Livun, Ana ; Tomasović- Lončarić, Čedna ; Štoos-Veić, Tajana ; Pejša, Vlatko ; Jakšić, Ozren ; Prka, Željko ; Kušec, Rajko

Izvornik
Clinical Lymphoma Myeloma & Leukemia (2152-2650) 16 (2016), 9; 523-526

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Philadelphia chromosome-negative myeloproliferative neoplasm ; anemia ; RT PCR ; fibrosis ; JAK2 V617F

Sažetak
Activation of the canonical wingless-related integration site (Wnt)/b-catenin signaling pathway is associated with malignant transformation, development of fibrosis, and angiogenesis. We analyzed b- catenin mRNA expression in bone marrow of 29 patients with primary (PMF), 4 with secondary (SMF) myelofibrosis, and 16 control participants using quantitative real- time polymerase chain reaction (qRT PCR). b- Catenin expression is increased in PMF and SMF and might potentiate anemia. Introduction: b-Catenin is a central effector molecule of the canonical wingless- related integration site (Wnt) signaling pathway. It is important for maintenance of stem cell homeostasis and its aberrant activation has been implicated in a wide array of malignant hematological disorders. There are few reports suggesting its dysregulation in Philadelphia chromosome-negative (Ph
) myeloproliferative neoplasms (MPNs). Patients and Methods: We analyzed b-catenin mRNA expression in bone marrow (BM) aspirates of 29 patients with primary (PMF) and 4 patients with secondary, post Ph
MPN, myelofibrosis (SMF) using quantitative real-time polymerase chain reaction (qRT PCR). The control group consisted of 16 BM aspirates from patients with limited- stage aggressive non-Hodgkin lymphoma without BM involvement. We compared relative gene expression with clinical and hematological parameters. Results: Relative expression of b- catenin differed significantly among groups (P ¼ .0002), it was significantly higher in patients with PMF and SMF than in the control group, but did not differ between patients with PMF and SMF. A negative correlation was found regarding hemoglobin level in PMF (P ¼ .017). No association according to Janus kinase 2 (JAK2) V617F mutational status or JAK2 V617F allele burden was detected. Conclusion: Our results show for the first time that b-catenin mRNA expression is increased in patients with PMF and SMF and its upregulation might potentiate anemia. A number of inflammatory cytokines associated with PMF are capable of mediating their effects through increased b- catenin expression. Accordingly, b-catenin can induce expression of a number of genes implicated in processes of cell cycle control, fibrosis, and angiogenesis, which are central to the PMF pathogenesis. Therefore, b-catenin might represent an interesting new therapeutic target in these diseases.

Izvorni jezik
Engleski

Znanstvena područja
Biologija, Temeljne medicinske znanosti

POVEZANOST RADA